J Jay Lobell's Net Worth
$1.34 Million
Who is J Jay Lobell?
J Jay Lobell has an estimated net worth of $1.34 Million. This is based on reported shares across multiple companies, which include Paramount Acquisition Corp, Innovive Pharmaceuticals, Inc., NORTON SOUND ACQUISITION CORP., SITKA SCIENCES, INC., PARDES BIOSCIENCES, INC., Fortress Biotech, Inc., MANHATTAN PHARMACEUTICALS INC, NOVADEL PHARMA INC, Hana Biosciences Inc, KERYX BIOPHARMACEUTICALS INC, and DENALI SCIENCES, INC..
SEC CIK
J Jay Lobell's CIK is 0001172659
Past Insider Trading and Trends
2007 was J Jay Lobell's most active year for acquiring shares with 21 total transactions. J Jay Lobell's most active month to acquire stocks was the month of December. 2023 was J Jay Lobell's most active year for disposing of shares, totalling 4 transactions. J Jay Lobell's most active month to dispose stocks was the month of July. 2023 saw J Jay Lobell paying a total of $249,999.84 for 436,901 shares, this is the most they've acquired in one year. In 2023 J Jay Lobell cashed out on 350,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Paramount Acquisition Corp No price found
CEO and Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.37% | 10.96K |
—
|
—
| 336.42K |
Jan 16
| |||
Form 4
| +0.31% | 1.02K |
—
|
—
| 325.46K |
Oct 16
| |||
Form 4
| +0.15% | 496 |
—
|
—
| 324.44K |
Jul 16
| |||
Form 4
| +0.15% | 481 |
—
|
—
| 323.95K |
Apr 16
| |||
Form 4
| +1.48% | 4.72K |
—
|
—
| 323.47K |
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Feb 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Feb 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Feb 16 - Feb 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Feb 13 - Feb 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Feb 9 - Feb 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Feb 6 - Feb 7
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Feb 2 - Feb 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Jan 31
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Jan 29 - Jan 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Jan 25
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17 - Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11 - Jan 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Innovive Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -162.67K |
—
|
—
|
0
|
Sep 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
NORTON SOUND ACQUISITION CORP. No price found
President and Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SITKA SCIENCES, INC. No price found
President and Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PARDES BIOSCIENCES, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.36M |
—
|
—
|
0
|
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| -62.02% | -2.23M |
—
|
—
| 1.36M |
Jul 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |